Pediatric Oncology

od Kurmasheva, Raushan T., Houghton, Peter J.
Izdano 2007

Identifying novel therapeutic agents using xenograft models of pediatric cancer

od Kurmasheva, Raushan T., Houghton, Peter J.
izdano v Cancer Chemother Pharmacol (2016)

Challenges and Opportunities for Childhood Cancer Drug Development

od Houghton, Peter J., Kurmasheva, Raushan T.
izdano v Pharmacol Rev (2019)

Developing New Agents for Treatment of Childhood Cancer: Challenges and Opportunities for Preclinical Testing

od Ghilu, Samson, Kurmasheva, Raushan T., Houghton, Peter J.
izdano v J Clin Med (2021)

Preclinical Childhood Sarcoma Models: Drug Efficacy Biomarker Identification and Validation

od Geier, Brian, Kurmashev, Dias, Kurmasheva, Raushan T., Houghton, Peter J.
izdano v Front Oncol (2015)

Recent Developments in Nanomedicine for Pediatric Cancer

od Yang, Shicheng, Wallach, Mia, Krishna, Apurva, Kurmasheva, Raushan, Sridhar, Srinivas
izdano v J Clin Med (2021)

Potent Inhibition of Angiogenesis by the IGF-1 Receptor-Targeting Antibody SCH717454 is Reversed by IGF-2

od Bid, Hemant K., Zhan, Jun, Phelps, Doris, Kurmasheva, Raushan T., Houghton, Peter J.
Izdano 2011

Nanoformulation of Talazoparib Increases Maximum Tolerated Doses in Combination With Temozolomide for Treatment of Ewing Sarcoma

od Baldwin, Paige, Likhotvorik, Rostislav, Baig, Nabeela, Cropper, Jodie, Carlson, Ruth, Kurmasheva, Raushan, Sridhar, Srinivas
izdano v Front Oncol (2019)

The IGF-1 Receptor Targeting Antibody, CP-751,871, Suppresses Tumor-Derived VEGF and Synergizes with Rapamycin in Models of Childhood Sarcoma

od Kurmasheva, Raushan T., Dudkin, Lorina, Billups, Catherine, Debelenko, Larisa V., Morton, Christopher L., Houghton, Peter J.
Izdano 2009

Initial Testing of the Multitargeted Kinase Inhibitor Pazopanib by the Pediatric Preclinical Testing Program

od Keir, Stephen T., Morton, Christopher L., Wu, Jianrong, Kurmasheva, Raushan T., Houghton, Peter J., Smith, Malcolm A.
izdano v Pediatr Blood Cancer (2011)

Initial Testing (Stage 1) of the Topoisomerase II inhibitor Pixantrone, by the Pediatric Preclinical Testing Program

od Kurmasheva, Raushan T., Reynolds, C. Patrick, Kang, Min H., Allievi, Cecilia, Houghton, Peter J., Smith, Malcolm A.
Izdano 2013

Initial Testing (Stage 1) of M6620 (formerly VX-970), a Novel ATR Inhibitor, alone and combined with Cisplatin and Melphalan, by the Pediatric Preclinical Testing Program

od Kurmasheva, Raushan T., Kurmashev, Dias, Reynolds, C. Patrick, Kang, Min, Wu, Jianwrong, Houghton, Peter J., Smith, Malcolm A.
izdano v Pediatr Blood Cancer (2017)

Prospective use of the Single Mouse Experimental Design for Evaluation of PLX038A

od Ghilu, Samson, Li, Qilin, Fontaine, Shaun D., Santi, Daniel V., Kurmasheva, Raushan T., Zheng, Siyuan, Houghton, Peter J.
izdano v Cancer Chemother Pharmacol (2020)

PCAT: an integrated portal for genomic and preclinical testing data of pediatric cancer patient-derived xenograft models

od Yang, Juechen, Li, Qilin, Noureen, Nighat, Fang, Yanbing, Kurmasheva, Raushan, Houghton, Peter J, Wang, Xiaojing, Zheng, Siyuan
izdano v Nucleic Acids Res (2020)

Initial Testing (Stage 1) of TAK-701, a humanized hepatocyte growth factor binding antibody, by the Pediatric Preclinical Testing Program

od Houghton, Peter J., Kurmasheva, Raushan T., Kolb, E. Anders, Wu, Jianrong, Gorlick, Richard, Maris, John M., Smith, Malcolm A.
Izdano 2013

Initial Testing (Stage 1) of Glembatumumab Vedotin (CDX-011) by the Pediatric Preclinical Testing Program

od Kolb, E. Anders, Gorlick, Richard, Billups, Catherine A., Hawthorne, Thomas, Kurmasheva, Raushan T., Houghton, Peter J., Smith, Malcolm A.
izdano v Pediatr Blood Cancer (2014)

ΔNp63 promotes pediatric neuroblastoma and osteosarcoma by regulating tumor angiogenesis

od Bid, Hemant K., Roberts, Ryan D., Cam, Maren, Audino, Anthony, Kurmasheva, Raushan T., Lin, Jiayuh, Houghton, Peter J., Cam, Hakan
Izdano 2013

Evaluation of Arsenic Trioxide by the Pediatric Preclinical Testing Program with a Focus on Ewing Sarcoma

od Smith, Malcolm A., Kang, Min H., Reynolds, C. Patrick, Kurmasheva, Raushan T., Alexander, Denise, Billups, Catherine A., Toretsky, Jeffrey A., Houghton, Peter J.
Izdano 2012

Inhibition of MDM2 by RG7388 Confers Hypersensitivity to X-radiation in Xenograft Models of Childhood Sarcoma

od Phelps, Doris A., Bondra, Kathryn, Seum, Star, Chronowski, Christopher, Leasure, Justin, Kurmasheva, Raushan T., Middleton, Steven, Wang, Dian, Mo, Xiaokui, Houghton, Peter J.
izdano v Pediatr Blood Cancer (2015)

Initial Testing (Stage 1) of Tazemetostat (EPZ-6438), a Novel EZH2 Inhibitor, by the Pediatric Preclinical Testing Program

od Kurmasheva, Raushan T., Sammons, Melissa, Favours, Edward, Wu, Jianwrong, Kurmashev, Dias, Cosmopoulos, Katherine, Keilhack, Heike, Klaus, Christine R., Houghton, Peter J., Smith, Malcolm A.
izdano v Pediatr Blood Cancer (2016)